Nordic Nanovector ASA: Invitation to First Quarter 2020 Results Webcast

On May 19, 2020 Nordic Nanovector ASA (OSE: NANO) reported that it will report its results for the first quarter 2020 on Tuesday, 26 May 2020 (Press release, Nordic Nanovector, MAY 19, 2020, View Source [SID1234558298]). A presentation by Nordic Nanovector’s senior management team will take place via a webcast at 08:30 am CET on the same day.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A link to the webcast and a presentation will be uploaded to the company’s homepage (www.nordicnanovector.com) at 07:00 am CET on Tuesday 26 May.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!